Citation Tools
Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0420 Secondary Efficacy Outcomes from a Phase 3 Study Support Clinical Equivalence Between BOW015 and Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- AB0420 Secondary Efficacy Outcomes from a Phase 3 Study Support Clinical Equivalence Between BOW015 and Infliximab in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses